Clinical Trial Update: Access II - Trial of Warfarin to Prevent Malfunction of Haemodialysis Catheters [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating warfarin to prevent malfunction of hemodialysis catheters in end-stage renal disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bleeding
• End-stage Renal Disease
• Thrombosis

Drugs mentioned

• Warfarin (warfarin)

Snippet

Sponsor: Hamilton Health Sciences Corporation | Conditions: End Stage Renal Disease, Thrombosis | Phase 3 | Status: COMPLETED